arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Nuveen Churchill Direct Lending Corp.

NCDL

$12.86 ▲ +0.37 (+2.96%) at close

26 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bearish

auto_awesome

Analytical Summary

Nuveen Churchill Direct Lending Corp. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $635.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC —

FCF / Share $-0.28

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity 1.32

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$8.69M

↓ -42.2% —

FCF / Share Free cash flow per share

$-0.28

↓ -64.9% —

Long-Term Debt Long-term obligations

$1.14B

↑ +2.3% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Returns →

Financial Health ↓

Cash Quality

Dividend History

Dividend / share · sourced from SEC filings

$0.50 Latest / share

+6.4% YoY

+31.0% 5-yr CAGR

$0.17

FY 2019

$0.28

FY 2020

$0.38

FY 2021

$0.47

FY 2022

$0.50

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
EPS Growth YoY (%)	—	-20.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-25.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-19.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-17.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	19.6% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	21.6% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	36.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-42.2% Weak ↓ Weak Declining Year-over-year change in net income	-45.9% Weak ↓ Weak Declining Year-over-year change in net income	-49.1% Weak ↓ Weak Declining Year-over-year change in net income	-20.7% Weak ↓ Weak Declining Year-over-year change in net income	-50.0% Weak ↓ Weak Declining Year-over-year change in net income	2.4% Caution ↓ Caution Declining Year-over-year change in net income	81.9% Excellent ↓ Excellent Declining Year-over-year change in net income	41.2% Excellent ↓ Excellent Declining Year-over-year change in net income	136.1% Excellent ↓ Excellent Declining Year-over-year change in net income	296.2% Excellent ↑ Excellent Improving Year-over-year change in net income	236.1% Excellent Excellent Year-over-year change in net income	N/M	88.4% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Growth YoY (%)	-64.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-9023.3% Weak Weak Year-over-year change in free cash flow	—	—	—	-29.4% Weak Weak Year-over-year change in free cash flow	—	—	—	57.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	-7.7% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-5.5% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	1.5% Caution Caution Compound annual EPS growth over 3 years	6.4% Fair Fair Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
FCF / Net Income (x)	-1.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.79x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	2.00x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	8.56x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-3.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-4.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-3.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-12.16x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-18.80x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	57.88x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-10.29x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
Return on Common Equity (%) (%)	1.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	1.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15%	2.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15%	1.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	1.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	3.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15%	3.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15%	3.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	2.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	1.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	1.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15%	-0.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15%	1.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15%	—	—	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
Debt to Equity (x)	1.32x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.27x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.25x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	1.26x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x	1.31x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x	1.15x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x	1.11x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x	1.04x Caution → Caution Stable Total debt relative to shareholder equity Optimal: < 0.6x	0.83x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x	—	1.36x Caution ↓ Caution Declining Total debt relative to shareholder equity Optimal: < 0.6x	1.48x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x	1.49x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$1.14B	$1.11B	$1.10B	$1.07B	$1.15B	$1.11B	$1.03B	$957.76M	$761.35M	—	$830.58M	$780.00M	$719.38M	—	$-37.51M	$-32.96M	$-23.34M	$-35.19M	—	—	—	—	—	—	—	—

📊 What does each share earn? 7 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
Basic EPS, GAAP (USD)	—	$0.44	$0.43	$0.46	$0.53	$0.55	$0.58	$0.57	$0.56	$0.67	$0.62	$0.60	$0.60	$0.56	$0.51	$0.44	$0.44	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.28	—	$0.75	$2.73	$-0.17	—	—	—	$-0.00	—	—	—	$-0.00	—	$-0.00	$-0.01	$-0.00	—	—	—	—	—	—	—	—	—
Dividend per Share (USD)	—	—	—	—	—	—	—	—	—	—	$0.50	$0.50	$0.50	—	$0.47	$0.43	$0.41	$0.38	$0.38	$0.31	$0.30	$0.28	$0.23	$0.28	$0.17	$0.17
Book Value per Share (USD)	$17.50	$17.72	$17.85	$17.92	$17.96	$18.18	$18.15	$18.03	$18.21	$18.13	$17.96	$17.93	$18.01	$18.32	$18.54	$18.76	$17.93	$19.39	—	—	—	$18.74	—	—	—	$20.00
Tangible Book Value per Share (USD)	$17.50	$17.72	$17.85	$17.92	$17.96	$18.18	$18.15	$18.03	$18.21	$18.13	$17.96	$17.93	$18.01	$18.32	$18.54	$18.76	$17.93	$19.39	—	—	—	$18.74	—	—	—	$20.00
Basic Weighted Avg Shares (shares)	49.39M	—	49.40M	50.18M	52.21M	—	54.69M	54.79M	52.76B	—	34.81B	30.62B	28.73B	—	24.49B	22.21B	20.51B	—	—	—	—	—	—	—	—	—
Dividend Payout Ratio (%)	—	—	—	—	—	—	—	—	—	—	80.6% Caution → Caution Stable Dividends paid as a percentage of earnings Optimal: 30-60%	83.3% Caution ↓ Caution Declining Dividends paid as a percentage of earnings Optimal: 30-60%	83.3% Caution ↓ Caution Declining Dividends paid as a percentage of earnings Optimal: 30-60%	—	92.2% Weak → Weak Stable Dividends paid as a percentage of earnings Optimal: 30-60%	97.7% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	93.2% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
LT Debt (USD)	$1.14B	$1.11B	$1.10B	$1.11B	$1.20B	$1.11B	$1.10B	$1.03B	$825.50M	—	$866.55M	$825.45M	$768.95M	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$864.11M	$875.18M	$881.49M	$887.74M	$920.02M	$970.32M	$990.61M	$986.37M	$998.23M	$747.88M	$638.96M	$557.50M	$517.54M	$524.96M	$470.78M	$425.77M	$374.05M	$374.05M	—	—	—	$157.64M	—	—	—	$66.21M

📋 What is driving earnings? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 29, 2021 10-Q ↗	Q2 FY2021 Jun 29, 2021 10-Q ↗	Q1 FY2021 Mar 29, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Nov 4, 2020 10-Q ↗	Q2 FY2020 Aug 4, 2020 10-Q ↗	Q1 FY2020 Apr 16, 2020 10-Q ↗	Q4 FY2019 Apr 16, 2020 10-K ↗
Net Income, GAAP (USD)	$8.69M	$15.92M	$18.66M	$16.02M	$15.02M	$29.45M	$36.64M	$20.20M	$30.02M	$28.77M	$20.15M	$14.31M	$12.72M	$7.26M	$6.00M	$-2.72M	$6.75M	—	—	—	—	—	—	—	—	—
Operating Cash Flow (USD)	$-13.74M	$28.57M	$37.25M	$137.15M	$-8.81M	$11.99M	—	—	$-97.56M	$-134.71M	—	—	$-41.06M	$-88.26M	$-112.70M	$-157.44M	$-69.45M	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Nuveen Churchill Direct Lending Corp.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Compare NCDL with peers